Compile Data Set for Download or QSAR
Report error Found 31 Enz. Inhib. hit(s) with all data for entry = 10031
TargetGalectin-3(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 509535BDBM509535(US11072626, Example 22)
Affinity DataIC50: 43nMAssay Description:ASSAY BUFFER Composition: 25 mM HEPES, 100 mM NaCl, 0.005% Tween 20, 0.05% BSA prepared in sterile water (all reagents from Sigma). PROTOCOL: The Gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 509530BDBM509530(US11072626, Example 2 | 3: (2R,3R,4S,5R,6R)-6-((R)...)
Affinity DataIC50: 46nMAssay Description:ASSAY BUFFER Composition: 25 mM HEPES, 100 mM NaCl, 0.005% Tween 20, 0.05% BSA prepared in sterile water (all reagents from Sigma). PROTOCOL: The Gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 509541BDBM509541(US11072626, Example 28)
Affinity DataIC50: 48nMAssay Description:ASSAY BUFFER Composition: 25 mM HEPES, 100 mM NaCl, 0.005% Tween 20, 0.05% BSA prepared in sterile water (all reagents from Sigma). PROTOCOL: The Gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 509546BDBM509546(US11072626, Example 33)
Affinity DataIC50: 60nMAssay Description:ASSAY BUFFER Composition: 25 mM HEPES, 100 mM NaCl, 0.005% Tween 20, 0.05% BSA prepared in sterile water (all reagents from Sigma). PROTOCOL: The Gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 509536BDBM509536(US11072626, Example 23)
Affinity DataIC50: 60nMAssay Description:ASSAY BUFFER Composition: 25 mM HEPES, 100 mM NaCl, 0.005% Tween 20, 0.05% BSA prepared in sterile water (all reagents from Sigma). PROTOCOL: The Gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 509556BDBM509556(US11072626, Example 55)
Affinity DataIC50: 70nMAssay Description:ASSAY BUFFER Composition: 25 mM HEPES, 100 mM NaCl, 0.005% Tween 20, 0.05% BSA prepared in sterile water (all reagents from Sigma). PROTOCOL: The Gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 509540BDBM509540(US11072626, Example 27)
Affinity DataIC50: 70nMAssay Description:ASSAY BUFFER Composition: 25 mM HEPES, 100 mM NaCl, 0.005% Tween 20, 0.05% BSA prepared in sterile water (all reagents from Sigma). PROTOCOL: The Gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 509542BDBM509542(US11072626, Example 29)
Affinity DataIC50: 72nMAssay Description:ASSAY BUFFER Composition: 25 mM HEPES, 100 mM NaCl, 0.005% Tween 20, 0.05% BSA prepared in sterile water (all reagents from Sigma). PROTOCOL: The Gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 509538BDBM509538(US11072626, Example 25)
Affinity DataIC50: 76nMAssay Description:ASSAY BUFFER Composition: 25 mM HEPES, 100 mM NaCl, 0.005% Tween 20, 0.05% BSA prepared in sterile water (all reagents from Sigma). PROTOCOL: The Gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 509539BDBM509539(US11072626, Example 26)
Affinity DataIC50: 86nMAssay Description:ASSAY BUFFER Composition: 25 mM HEPES, 100 mM NaCl, 0.005% Tween 20, 0.05% BSA prepared in sterile water (all reagents from Sigma). PROTOCOL: The Gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 509544BDBM509544(US11072626, Example 31)
Affinity DataIC50: 90nMAssay Description:ASSAY BUFFER Composition: 25 mM HEPES, 100 mM NaCl, 0.005% Tween 20, 0.05% BSA prepared in sterile water (all reagents from Sigma). PROTOCOL: The Gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 509537BDBM509537(US11072626, Example 24)
Affinity DataIC50: 150nMAssay Description:ASSAY BUFFER Composition: 25 mM HEPES, 100 mM NaCl, 0.005% Tween 20, 0.05% BSA prepared in sterile water (all reagents from Sigma). PROTOCOL: The Gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 509533BDBM509533(US11072626, Example 5)
Affinity DataIC50: 195nMAssay Description:ASSAY BUFFER Composition: 25 mM HEPES, 100 mM NaCl, 0.005% Tween 20, 0.05% BSA prepared in sterile water (all reagents from Sigma). PROTOCOL: The Gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 509531BDBM509531(US11072626, Example 3)
Affinity DataIC50: 200nMAssay Description:ASSAY BUFFER Composition: 25 mM HEPES, 100 mM NaCl, 0.005% Tween 20, 0.05% BSA prepared in sterile water (all reagents from Sigma). PROTOCOL: The Gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 509532BDBM509532(US11072626, Example 4)
Affinity DataIC50: 224nMAssay Description:ASSAY BUFFER Composition: 25 mM HEPES, 100 mM NaCl, 0.005% Tween 20, 0.05% BSA prepared in sterile water (all reagents from Sigma). PROTOCOL: The Gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 509534BDBM509534(US11072626, Example 21)
Affinity DataIC50: 225nMAssay Description:ASSAY BUFFER Composition: 25 mM HEPES, 100 mM NaCl, 0.005% Tween 20, 0.05% BSA prepared in sterile water (all reagents from Sigma). PROTOCOL: The Gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 509555BDBM509555(US11072626, Example 54)
Affinity DataIC50: 230nMAssay Description:ASSAY BUFFER Composition: 25 mM HEPES, 100 mM NaCl, 0.005% Tween 20, 0.05% BSA prepared in sterile water (all reagents from Sigma). PROTOCOL: The Gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 509553BDBM509553(US11072626, Example 52)
Affinity DataIC50: 250nMAssay Description:ASSAY BUFFER Composition: 25 mM HEPES, 100 mM NaCl, 0.005% Tween 20, 0.05% BSA prepared in sterile water (all reagents from Sigma). PROTOCOL: The Gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 509558BDBM509558(US11072626, Example 57)
Affinity DataIC50: 310nMAssay Description:ASSAY BUFFER Composition: 25 mM HEPES, 100 mM NaCl, 0.005% Tween 20, 0.05% BSA prepared in sterile water (all reagents from Sigma). PROTOCOL: The Gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 509551BDBM509551(US11072626, Example 50)
Affinity DataIC50: 620nMAssay Description:ASSAY BUFFER Composition: 25 mM HEPES, 100 mM NaCl, 0.005% Tween 20, 0.05% BSA prepared in sterile water (all reagents from Sigma). PROTOCOL: The Gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 509547BDBM509547(US11072626, Example 34)
Affinity DataIC50: 660nMAssay Description:ASSAY BUFFER Composition: 25 mM HEPES, 100 mM NaCl, 0.005% Tween 20, 0.05% BSA prepared in sterile water (all reagents from Sigma). PROTOCOL: The Gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 509545BDBM509545(US11072626, Example 32)
Affinity DataIC50: 700nMAssay Description:ASSAY BUFFER Composition: 25 mM HEPES, 100 mM NaCl, 0.005% Tween 20, 0.05% BSA prepared in sterile water (all reagents from Sigma). PROTOCOL: The Gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 509549BDBM509549(US11072626, Example 48)
Affinity DataIC50: 740nMAssay Description:ASSAY BUFFER Composition: 25 mM HEPES, 100 mM NaCl, 0.005% Tween 20, 0.05% BSA prepared in sterile water (all reagents from Sigma). PROTOCOL: The Gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 509543BDBM509543(US11072626, Example 30)
Affinity DataIC50: 800nMAssay Description:ASSAY BUFFER Composition: 25 mM HEPES, 100 mM NaCl, 0.005% Tween 20, 0.05% BSA prepared in sterile water (all reagents from Sigma). PROTOCOL: The Gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 509559BDBM509559(US11072626, Example 58)
Affinity DataIC50: 840nMAssay Description:ASSAY BUFFER Composition: 25 mM HEPES, 100 mM NaCl, 0.005% Tween 20, 0.05% BSA prepared in sterile water (all reagents from Sigma). PROTOCOL: The Gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 509550BDBM509550(US11072626, Example 49)
Affinity DataIC50: 1.34E+3nMAssay Description:ASSAY BUFFER Composition: 25 mM HEPES, 100 mM NaCl, 0.005% Tween 20, 0.05% BSA prepared in sterile water (all reagents from Sigma). PROTOCOL: The Gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 509548BDBM509548(US11072626, Example 47)
Affinity DataIC50: 1.53E+3nMAssay Description:ASSAY BUFFER Composition: 25 mM HEPES, 100 mM NaCl, 0.005% Tween 20, 0.05% BSA prepared in sterile water (all reagents from Sigma). PROTOCOL: The Gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 509552BDBM509552(US11072626, Example 51)
Affinity DataIC50: 1.61E+3nMAssay Description:ASSAY BUFFER Composition: 25 mM HEPES, 100 mM NaCl, 0.005% Tween 20, 0.05% BSA prepared in sterile water (all reagents from Sigma). PROTOCOL: The Gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 509554BDBM509554(US11072626, Example 53)
Affinity DataIC50: 1.75E+3nMAssay Description:ASSAY BUFFER Composition: 25 mM HEPES, 100 mM NaCl, 0.005% Tween 20, 0.05% BSA prepared in sterile water (all reagents from Sigma). PROTOCOL: The Gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 509560BDBM509560(US11072626, Example 59)
Affinity DataIC50: 5.55E+3nMAssay Description:ASSAY BUFFER Composition: 25 mM HEPES, 100 mM NaCl, 0.005% Tween 20, 0.05% BSA prepared in sterile water (all reagents from Sigma). PROTOCOL: The Gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetGalectin-3(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 509557BDBM509557(US11072626, Example 56)
Affinity DataIC50: 7.43E+3nMAssay Description:ASSAY BUFFER Composition: 25 mM HEPES, 100 mM NaCl, 0.005% Tween 20, 0.05% BSA prepared in sterile water (all reagents from Sigma). PROTOCOL: The Gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent